Saftey
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects (NCT07055412) | Neurodawn Pharmaceutical Co., Ltd. | 2025-07-10 |
Track Saftey automatically
Every clearance here is in the API, with alerts when new ones post.